Laminar Pharma Announces first open-label Progression-Free Survival data for LAM561 in combination with standard of Care in First-Line Therapy for Newly Diagnosed Glioblastoma MGMT-methylated patients

PALMA DE MALLORCA,Spain,March 5,2025-- LaminarPharma,a leader in the development of innovative cancer therapy based on membrane lipid therapy,announced today optimistic results from its ongoing clini

Tribal

Mar 6, 2025

Ascend Advanced Therapies Appoints John Chiminski as Chair and Karen Flynn as Independent Director

ROCKVILLE,Md.,March 5,2025-- Ascend Advanced Therapies (Ascend),a gene to GMP advanced therapy development partner,today announced the appointment of John Chiminski and Karen Flynn as non-executive m

Tribal

Mar 6, 2025

CARsgen's Claudin18.2 CAR-T Therapy Satri-cel Granted Breakthrough Therapy Designation by the NMPA

SHANGHAI,March 3,2025-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors

Tribal

Mar 5, 2025

Yuwell Medical Joins CFA Team China as Official Partner: Elevating Health Celebrating Sport

BEIJING,March 3,2025-- On March 2,Yuwell Medical and the CFA Team China announced an official partnership at a signing ceremony in Beijing under the theme "Elevating Health Celebrating Sport.&quo

Tribal

Mar 5, 2025

ANICAV to participate in Foodex Japan 2025 with Cooking Demos and Tasting Sessions highlighting Red Gold Tomatoes from Europe

TOKYO,March 3,2025-- ANICAV,the Italian National Association of Canned Vegetable Industries,is thrilled to announce its participation in Foodex Japan 2025,taking place from 11 to 14 March 2025.

Tribal

Mar 5, 2025

HONOR Unveils Groundbreaking AI-Powered Earbuds Open at MWC 2025

BARCELONA,Spain,March 3,2025-- Global technology brand HONOR today announced the HONOR ALPHA PLAN,a new corporate strategy to transform HONOR from a smartphone maker to a global leading AI device eco

Tribal

Mar 5, 2025

Tribal

Laminar Pharma Announces first open-label Progression-Free Survival data for LAM561 in combination with standard of Care in First-Line Therapy for Newly Diagnosed Glioblastoma MGMT-methylated patients

Ascend Advanced Therapies Appoints John Chiminski as Chair and Karen Flynn as Independent Director

CARsgen&#039;s Claudin18.2 CAR-T Therapy Satri-cel Granted Breakthrough Therapy Designation by the NMPA

Yuwell Medical Joins CFA Team China as Official Partner: Elevating Health Celebrating Sport

ANICAV to participate in Foodex Japan 2025 with Cooking Demos and Tasting Sessions highlighting Red Gold Tomatoes from Europe

HONOR Unveils Groundbreaking AI-Powered Earbuds Open at MWC 2025

CARsgen's Claudin18.2 CAR-T Therapy Satri-cel Granted Breakthrough Therapy Designation by the NMPA